Search results with tag "Liraglutide"
PRODUCT MONOGRAPH
www.novonordisk.caSAXENDA® (liraglutide) Page 1 of 47. PRODUCT MONOGRAPH. SAXENDA®. liraglutide . 6 mg/mL . Solution for Injection in a pre-filled pen . Human Glucagon Like Peptide-1 (GLP-1) Weight Management
Diabetes and the Older Adult
professional.diabetes.org– Lower CVD event rate and mortality in CVD (liraglutide) – May be associated with nausea, vomiting, and diarrhea – High cost, injectable • DPP-4 Inhibitors – Minimal hypoglycemia – Possible angioedema/urticaria and other immune- mediated dermatological effects
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
pi.lilly.comin patients treated with liraglutide, another GLP-1 receptor agonist, have been reported inthe postmarketing period; the data in these reports are insufficient to establish or exclude a causalrelationship between MTC and GLP-1 receptor agonist use in humans.
HIGHLIGHTS OF PRESCRIBING INFORMATION - novo-pi.com
www.novo-pi.comXultophy ® 100/3.6 (insulin egludec nd iraglutide injection) 2 FULL PRESCRIBING INFORMATION WARNING: RISK OF THYROID C-CELL TUMORS • Liraglutide, one of the components of XULTOPHY® 100/3.6, causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically